Answers are grounded in this paper and cite their sources.
Laryngopharyngeal reflux (LPR) commonly causes voice disturbances, yet treatment efficacy remains debated. This review synthesizes evidence on voice outcomes in patients with LPR. A Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)-guided systematic review (2000-2024) identified eight studies evaluating pharmacological, behavioral, and diagnostic approaches. Random-effects meta-analyses were conducted to assess effect sizes (ES), heterogeneity (I²), and subgroup differences. Behavioral interventions (e.g., Lee Silverman Voice Treatment {LSVT}, voice therapy) demonstrated robust efficacy (ES=0.60, 95% CI: 0.45-0.76, I²=0%), whereas proton pump inhibitors (PPIs) showed negligible effects (ES = -0.15). Adjunctive rikkunshito significantly improved outcomes in refractory LPR cases (ES=0.82). Diagnostic methods based on acoustic analysis or the Voice Handicap Index (VHI) yielded more reliable outcomes (ES=0.56) than those based on clinical symptoms or the Reflux Symptom Index (RSI) (ES=0.32, I²=94.45%). Long-term benefits beyond six months were inconsistent (ES=0.25, I²=97.47%). Behavioral therapies outperform pharmacological treatments in managing LPR-related voice dysfunction, though diagnostic precision and long-term adherence remain critical. Future studies should prioritize standardized diagnostic protocols and investigate multimodal therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Rajput et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: